Women aged 50 to 69 who underwent mammography screening had a reduced death rate compared to women who did not have mammography screening.
Mammography screening may reduce deaths from breast cancer by about 28 percent, according to a study published in BMJ.
Researchers from Norway undertook a prospective cohort study to evaluate the effectiveness of contemporary mammography screening. The study included all Norwegian women, aged 50 to 79, who were followed between 1986 and 2009. A national screening program had been gradually implemented from 1995 to 2005, and biennial invitations were sent to women aged 50 to 69.
The researchers compared deaths from breast cancer among women who were invited to screening with those who were not invited. A clear distinction was made between cases of breast cancer diagnosed before (without potential for screening effect) and after (with potential for screening effect) the first invitation for screening. The Cancer Intervention and Surveillance Modeling Network (CISNET) Stanford simulation model was used to estimate how many women would need to be invited to biennial mammography screening in the age group of 50 to 69 to prevent one breast cancer death during their lifetime.
The results showed that based on 15,193,034 person years of observation, 1,175 of the women invited to screening died from breast cancer, while 8,996 of the women who were not invited died from breast cancer. “After adjustment for age, birth cohort, county of residence, and national trends in deaths from breast cancer, the mortality rate ratio associated with being invited to mammography screening was 0.72 (95 percent confidence interval 0.64 to 0.79). To prevent one death from breast cancer, 368 (95 percent confidence interval 266 to 508) women would need to be invited to screening,” the authors wrote.
The invitation to mammography screening appeared to be associated with a 28 percent reduced risk of death from breast cancer compared with not being invited to screening, the researchers concluded.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.